Grand Forks Herald
HEADLINES: NORTH DAKOTA
N.D. drug settlement: North Dakota has received nearly $200,000 as part of a nationwide settlement paid to states by Bristol-Myers Squibb regarding allegations that the company engaged in illegal drug marketing and pricing with state Medicaid programs.
The settlement payments went to 43 states, the District of Columbia and the federal government.
The total settlement is $389 million plus interest. North Dakota got $194,873.
The allegations involved inflated prices; illegally paying doctors, health care providers and pharmacies money to induce them to purchase Bristol-Myers Squibb products; misreporting the price of antidepressant medication Serzone; and promoting the use of Abilify, an antipsychotic drug, for children and people with dementia, which are uses the Food and Drug Administration hasn’t approved.